| [1] |
Caccamo G, Saffioti F, Raimondo G. Hepatitis B virus and hepatitis C virus dual infection[J]. World J Gastroenterol,2014,20(40):14559- 14567.
|
| [2] |
Chu CJ, Lee SD. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment[J]. J Gastroenterol Hepatol,2008,23(4):512-520.
|
| [3] |
Liu CJ, Chen PJ. Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection[J]. World J Gastroenterol, 2014,20(11):2955-2961.
|
| [4] |
Hamzaoui L, El Bouchtili S, Siai K, et al. Hepatitis B virus and hepatitis C virus co-infection: a therapeutic challenge[J]. Clin Res Hepatol Gastroenterol,2013,37(1):e16-e20.
|
| [5] |
Potthoff A, Manns MP, Wedemeyer H. Treatment of HBV/HCV coinfection[J]. Expert Opin Pharmacother,2010,11(6):919-928.
|
| [6] |
Liu C J, Chu Y T, Shau W Y, et al. Treatment of patients with dual hepatitis C and B by peginterferon alpha and ribavirin reduced risk of hepatocellular carcinoma and mortality[J]. Gut,2014,63(3):506-514.
|
| [7] |
Yu ML, Lee CM, Chen CL, et al. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up[J]. Hepatology,2013,57(6):2135-2142.
|
| [8] |
European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2016[J]. J Hepatol,2017,66(1):153-194.
|
| [9] |
De Monte A, Courjon J, Anty R, et al. Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge[J]. J Clin Virol,2016,78(1):27-30.
|
| [10] |
Collins JM, Raphael KL, Terry C, et al. Hepatitis B virus reactivation during successful treatment of hepatitis C virus with sofosbuvir and simeprevir[J]. Clin Infect Dis,2015,61(8):1304-1306.
|
| [11] |
Ende AR, Kim NH, Yeh MM, et al. Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: a case report[J]. J Med Case Rep,2015,9(1):164.
|
| [12] |
Mekky MA, Nasr AM, Saleh MA, et al. Virologic and histologic characterisation of dual hepatitis B and C co-infection in Egyptian patients[J]. Arab J Gastroenterol,2013,14(4):143-147.
|
| [13] |
Konstantinou D, Deutsch M. The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management[J]. Ann Gastroenterol,2015,28(2):221-228.
|
| [14] |
Caccamo G, Saffioti F, Raimondo G. Hepatitis B virus and hepatitis C virus dual infection[J]. World J Gastroenterol,2014,20(40):14559- 14567.
|
| [15] |
Huang YT, Jen CL, Yang HI, et al. Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C[J]. J Clin Oncol,2011,29(27):3643-3650.
|
| [16] |
Raimondo G, Brunetto MR, Pontisso P, et al. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients[J]. Hepatology,2006,43(1):100-107.
|
| [17] |
Potthoff A, Berg T, Wedemeyer H. Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin[J]. Scand J Gastroenterol,2009,44(12):1487-1490.
|
| [18] |
European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection[J]. J Hepatol,2017,67(2):370-398.
|
| [19] |
Liu CJ, Chen PJ, Chen DS, et al. Perspectives on dual hepatitis B and C infection in Taiwan[J]. J Formos Med Assoc,2016,115(5):298-305.
|
| [20] |
Yeh ML, Hung CH, Huang JF, et al. Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses[J]. PLoS One,2011,6(6):e20752.
|
| [21] |
Liu JY, Sheng YJ, Hu HD, et al. The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis[J]. Virol J,2012,9:186.
|
| [22] |
Coppola N, Stanzione M, Messina V, et al. DAA-based regimens in HBsAg/anti-HCV positive patients: the need to control HBV replication to avoid HBV reactivation[J]. J Hepatol,2017,66(Suppl 1):727.
|
| [23] |
Preda C, Popescu C, Constantinescu I, et al. Outcome of patients with compensated liver cirrhosis with hepatitis B virus + hepatitis C virus coinfection treated with paritaprevir/ombitasvir/ritonavir, dasabuvir with ribavirin: a national cohort study[J]. J Hepatol,2017,66(Suppl 1):295-296.
|
| [24] |
Wang C, Li B, Chen J, et al. Hepatitis B reactivation after interferon-based therapy versus pan-oral direct acting antiviral agents in chronic hepatitis C patients co-infected with hepatitis B virus: a systematic review and meta-analysis[J]. Hepatology,2016,64(Suppl 1):461A.
|
| [25] |
Wahle R C, Perez R M, Pereira P F, et al. Hepatitis B virus reactivation after treatment for hepatitis C in hemodialysis patients with HBV/HCV coinfection[J]. Braz J Infect Dis,2015,19(5):533-537.
|
| [26] |
Coppola N, Pisapia R, Tonziello G, et al. Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection[J]. Antivir Ther,2008,13(2):307-318.
|
| [27] |
Pontisso P, Gerotto M, Benvegnu L, et al. Coinfection by hepatitis B virus and hepatitis C virus[M]. 1998:137-142.
|
| [28] |
Londoño MC, Lens S, Mariño Z, et al. Hepatitis B (HBV) reactivation during anti-hepatitis C (HCV) therapy with interferon (IFN)-free regimens: a prospective study[J]. Hepatology,2016,64(Suppl 1):297A.
|
| [29] |
Kawagishi N, Suda G, Onozawa M, et al. Prevalence and risk factors of hepatitis B virus reactivation in interferon-free direct-acting antiviral therapies for hepatitis C[J]. J Hepatol,2017,66(Suppl 1):725-726.
|
| [30] |
Belperio PS, Shahoumian TA, Mole LA, et al. Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals[J]. Hepatology,2017,66(1):27-36.
|
| [31] |
Chen GF, Wang C, Chen J, et al. Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: a systematic review and metaanalysis[J]. J Hepatol,2017,66(Suppl 1):296-297.
|